Key enzyme Rv3400 needed for trehalose use in TB
Gerald Larrouy‐Maumus reports that deleting rv3400 causes a 30-fold rise in β-D-glucose 1-phosphate and impairs trehalose use in Mycobacterium tuberculosis.
Mycobacterium tuberculosis kills over a million people each year, and scientists are working to understand how this bacterium survives inside people. To design better ways to treat and control Tuberculosis (TB), researchers need to learn how the microbe adapts its metabolism during infection. In work led by corresponding author Gerald Larrouy‐Maumus, scientists focused on a gene called rv3400. Earlier enzymological studies had suggested that rv3400 encodes a β-phosphoglucomutase, an enzyme type that can rearrange sugar phosphates inside cells, but the actual role of this gene in M. tuberculosis metabolism had not been tested. The new study deleted the rv3400 gene in M. tuberculosis and then examined what happened to sugar molecules and growth. The research shows clear changes in the bacterium’s internal sugars and its ability to grow when relying on a particular disaccharide called trehalose. These findings sharpen our picture of how M. tuberculosis handles trehalose, a compound known to be important to mycobacterial physiology and virulence.
The researchers compared a normal strain of Mycobacterium tuberculosis with a strain where the rv3400 gene had been removed. They measured levels of specific sugar phosphates and monitored growth on different food sources. Deletion of rv3400 produced a dramatic change: the amount of β-D-glucose 1-phosphate rose about 30-fold, a result the authors interpret as confirmation that rv3400’s main activity is β-phosphoglucomutase. The mutant strain also showed a clear growth defect when trehalose was provided as the only carbon source, indicating the enzyme is needed for optimal use of trehalose. The paper also reports on the characterisation of the strain lacking a β-phosphoglucomutase, encoded by the gene rv3400, and summarizes these measurements as evidence that Rv3400 is required for the catabolism of trehalose in M. tuberculosis.
These findings are significant because trehalose metabolism is described as a cornerstone of Mycobacterium tuberculosis physiology and virulence, and understanding it better could help fight TB. By pinpointing Rv3400 as a β-phosphoglucomutase that influences levels of β-D-glucose 1-phosphate and the bacterium’s ability to grow on trehalose, the study clarifies one step in the metabolic network that supports persistence and survival. The authors emphasize that a better understanding of trehalose metabolism is needed to develop novel strategies to eradicate Tuberculosis, and the data presented here provide specific evidence that Rv3400 plays a required role in trehalose catabolism. This gives researchers a clearer target for future studies aimed at disrupting the bacterium’s metabolism as part of new treatment or control approaches.
Identifying Rv3400 as required for trehalose breakdown improves understanding of a core metabolic pathway in Mycobacterium tuberculosis. This knowledge may guide development of new strategies to treat and control Tuberculosis.
Author: Yi Liu